A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer

Boleslav Kosharskyy, Nicolas Solban, Sung K. Chang, Imran Rizvi, Yuchiao Chang, Tayyaba Hasan

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Therapy-induced stimulation of angiogenic molecules can promote tumor angiogenesis leading to enhanced tumor growth and cancer metastasis. Several standard and emerging therapies, such as radiation and photodynamic therapy (PDT), can induce angiogenic molecules, thus limiting their effectiveness. PDT is approved for the treatment of several cancers; however, its induction of vascular endothelial growth factor (VEGF) creates conditions favorable to enhanced tumor growth and metastasis, therefore mitigating its cytotoxic and antivascular effects. This is the first report showing that subcurative PDT in an orthotopic model of prostate cancer (LNCaP) increases not only VEGF secretion (2.1-fold) but also the fraction of animals with lymph node metastases. PDT followed by administration of an antiangiogenic agent, TNP-470, abolished this increase and reduced local tumor growth. On the other hand, administration of TNP-470 before PDT was less effective at local tumor control. In addition, animals in all groups, except in the PDT + TNP-470 group, had a weight loss of >3 g at the time of sacrifice; the weight of the animals in the PDT + TNP-470 group did not change. The significant reduction (P < 0.05) in tumor weight and volume observed between the PDT + TNP-470 group and the control group suggests that the combination of PDT and antiangiogenic treatment administered in the appropriate sequence was not only more effective at controlling local tumor growth and metastases but also reduced disease-related toxicities. Such molecular response-based combinations merit further investigations as they enhance both monotherapies and lead to improved treatment outcomes.

Original languageEnglish (US)
Pages (from-to)10953-10958
Number of pages6
JournalCancer Research
Volume66
Issue number22
DOIs
StatePublished - Nov 15 2006
Externally publishedYes

Fingerprint

Photochemotherapy
Prostatic Neoplasms
Neoplasm Metastasis
Growth
Neoplasms
Therapeutics
Tumor Burden
Vascular Endothelial Growth Factor A
Angiogenesis Inhibitors
Weight Loss
Radiotherapy
Lymph Nodes
O-(chloroacetylcarbamoyl)fumagillol
Weights and Measures
Control Groups

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer. / Kosharskyy, Boleslav; Solban, Nicolas; Chang, Sung K.; Rizvi, Imran; Chang, Yuchiao; Hasan, Tayyaba.

In: Cancer Research, Vol. 66, No. 22, 15.11.2006, p. 10953-10958.

Research output: Contribution to journalArticle

Kosharskyy, Boleslav ; Solban, Nicolas ; Chang, Sung K. ; Rizvi, Imran ; Chang, Yuchiao ; Hasan, Tayyaba. / A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer. In: Cancer Research. 2006 ; Vol. 66, No. 22. pp. 10953-10958.
@article{76824741a7fd4535a84a75fce5e18406,
title = "A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer",
abstract = "Therapy-induced stimulation of angiogenic molecules can promote tumor angiogenesis leading to enhanced tumor growth and cancer metastasis. Several standard and emerging therapies, such as radiation and photodynamic therapy (PDT), can induce angiogenic molecules, thus limiting their effectiveness. PDT is approved for the treatment of several cancers; however, its induction of vascular endothelial growth factor (VEGF) creates conditions favorable to enhanced tumor growth and metastasis, therefore mitigating its cytotoxic and antivascular effects. This is the first report showing that subcurative PDT in an orthotopic model of prostate cancer (LNCaP) increases not only VEGF secretion (2.1-fold) but also the fraction of animals with lymph node metastases. PDT followed by administration of an antiangiogenic agent, TNP-470, abolished this increase and reduced local tumor growth. On the other hand, administration of TNP-470 before PDT was less effective at local tumor control. In addition, animals in all groups, except in the PDT + TNP-470 group, had a weight loss of >3 g at the time of sacrifice; the weight of the animals in the PDT + TNP-470 group did not change. The significant reduction (P < 0.05) in tumor weight and volume observed between the PDT + TNP-470 group and the control group suggests that the combination of PDT and antiangiogenic treatment administered in the appropriate sequence was not only more effective at controlling local tumor growth and metastases but also reduced disease-related toxicities. Such molecular response-based combinations merit further investigations as they enhance both monotherapies and lead to improved treatment outcomes.",
author = "Boleslav Kosharskyy and Nicolas Solban and Chang, {Sung K.} and Imran Rizvi and Yuchiao Chang and Tayyaba Hasan",
year = "2006",
month = "11",
day = "15",
doi = "10.1158/0008-5472.CAN-06-1793",
language = "English (US)",
volume = "66",
pages = "10953--10958",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer

AU - Kosharskyy, Boleslav

AU - Solban, Nicolas

AU - Chang, Sung K.

AU - Rizvi, Imran

AU - Chang, Yuchiao

AU - Hasan, Tayyaba

PY - 2006/11/15

Y1 - 2006/11/15

N2 - Therapy-induced stimulation of angiogenic molecules can promote tumor angiogenesis leading to enhanced tumor growth and cancer metastasis. Several standard and emerging therapies, such as radiation and photodynamic therapy (PDT), can induce angiogenic molecules, thus limiting their effectiveness. PDT is approved for the treatment of several cancers; however, its induction of vascular endothelial growth factor (VEGF) creates conditions favorable to enhanced tumor growth and metastasis, therefore mitigating its cytotoxic and antivascular effects. This is the first report showing that subcurative PDT in an orthotopic model of prostate cancer (LNCaP) increases not only VEGF secretion (2.1-fold) but also the fraction of animals with lymph node metastases. PDT followed by administration of an antiangiogenic agent, TNP-470, abolished this increase and reduced local tumor growth. On the other hand, administration of TNP-470 before PDT was less effective at local tumor control. In addition, animals in all groups, except in the PDT + TNP-470 group, had a weight loss of >3 g at the time of sacrifice; the weight of the animals in the PDT + TNP-470 group did not change. The significant reduction (P < 0.05) in tumor weight and volume observed between the PDT + TNP-470 group and the control group suggests that the combination of PDT and antiangiogenic treatment administered in the appropriate sequence was not only more effective at controlling local tumor growth and metastases but also reduced disease-related toxicities. Such molecular response-based combinations merit further investigations as they enhance both monotherapies and lead to improved treatment outcomes.

AB - Therapy-induced stimulation of angiogenic molecules can promote tumor angiogenesis leading to enhanced tumor growth and cancer metastasis. Several standard and emerging therapies, such as radiation and photodynamic therapy (PDT), can induce angiogenic molecules, thus limiting their effectiveness. PDT is approved for the treatment of several cancers; however, its induction of vascular endothelial growth factor (VEGF) creates conditions favorable to enhanced tumor growth and metastasis, therefore mitigating its cytotoxic and antivascular effects. This is the first report showing that subcurative PDT in an orthotopic model of prostate cancer (LNCaP) increases not only VEGF secretion (2.1-fold) but also the fraction of animals with lymph node metastases. PDT followed by administration of an antiangiogenic agent, TNP-470, abolished this increase and reduced local tumor growth. On the other hand, administration of TNP-470 before PDT was less effective at local tumor control. In addition, animals in all groups, except in the PDT + TNP-470 group, had a weight loss of >3 g at the time of sacrifice; the weight of the animals in the PDT + TNP-470 group did not change. The significant reduction (P < 0.05) in tumor weight and volume observed between the PDT + TNP-470 group and the control group suggests that the combination of PDT and antiangiogenic treatment administered in the appropriate sequence was not only more effective at controlling local tumor growth and metastases but also reduced disease-related toxicities. Such molecular response-based combinations merit further investigations as they enhance both monotherapies and lead to improved treatment outcomes.

UR - http://www.scopus.com/inward/record.url?scp=33845325814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845325814&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-06-1793

DO - 10.1158/0008-5472.CAN-06-1793

M3 - Article

VL - 66

SP - 10953

EP - 10958

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 22

ER -